Integrated Diagnostics (LON:IDHC) Shares Down 14.5% – Here’s Why

Shares of Integrated Diagnostics Holdings plc (LON:IDHC) dropped 14.5% on Friday . The company traded as low as GBX 0.52 and last traded at GBX 0.52. Approximately 229,814 shares were traded during trading, an increase of 15% from the average daily volume of 199,824 shares. The stock had previously closed at GBX 0.61.

Integrated Diagnostics Stock Performance

The company has a market cap of £3.02 million, a price-to-earnings ratio of 0.00, a P/E/G ratio of 7.65 and a beta of 0.38. The company’s fifty day moving average is GBX 0.54 and its two-hundred day moving average is GBX 0.58.

About Integrated Diagnostics

IDH is a leading diagnostics services provider in the Middle East and Africa offering a broad range of clinical pathology and
radiology tests to patients in Egypt, Jordan, Nigeria, Saudi Arabia, and Sudan. The Group’s core brands include Al Borg, Al Borg
Scan and Al Mokhtabar in Egypt, as well as Biolab (Jordan), Echo-Lab (Nigeria), Ultralab and Al Mokhtabar Sudan (both in Sudan),
and Biolab KSA (Saudi Arabia). With over 40 years of experience, a long track record for quality and safety has earned the Company
a trusted reputation, as well as internationally recognised accreditations for its portfolio of over 3,000 diagnostics tests.